I think their strategy seems quite clear. To pursue progressing these indications ourselves, probably with financial help if we have to beyond the first 2, unless market/offer is prepared to value us fairly.
The MC and income of NEU are many multiples higher on successful Ph3 and approval of even 1 indication so if market does not bridge that gap to an extent than I would expect JP to continue progressing as we currently are. That would represent shareholders best interests, failing a TO that recognises this and bridges some of the valuation gap.
I think their strategy seems quite clear. To pursue progressing...
-
- There are more pages in this discussion • 1,502 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.13 |
Change
-0.010(0.07%) |
Mkt cap ! $1.933B | |||
| Open | High | Low | Value | Volume |
| $15.04 | $15.30 | $14.96 | $6.401M | 422.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1 | $15.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.16 | 6015 | 1 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |